Dose adjustment for normal eating (DAFNE) - An audit of outcomes in Australia

Medical Journal of Australia

Volumn 192, Issue 11, 2010, Pages 637-640

  McIntyre, H David ^a   Knight, Brigid A ^b   Harvey, Dianne M ^c   Noud, Marina N ^b   Hagger, Virginia L ^c   Gilshenan, Kristen S ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER HOSPITAL   (Australia)

^c Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BODY WEIGHT; CARBOHYDRATE INTAKE; DIABETES CONTROL; DIABETES EDUCATION; DIABETIC DIET; DIABETIC KETOACIDOSIS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MICROALBUMINURIA; OBESITY; OUTCOME ASSESSMENT; PATIENT PARTICIPATION; QUALITY OF LIFE; RATING SCALE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 77953485265     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03662.x     Document Type: Article

References (16)

1. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325: 746.
2. Mühlhauser I, Bruckner I, Berger M, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf study. Diabetologia 1987; 30: 681-690. (Pubitemid 17155773)
3. National Health and Medical Research Council. When does quality assurance in health care require independent ethical review? Canberra: NHMRC, 2003.
4. Shaban MC, Fosbury J, Kerr D, Cavan DA. The prevalence of depression and anxiety in adults with Type 1 diabetes. Diabet Med 2006; 23: 1381-1384. (Pubitemid 44787805)
5. Welch G, Weinger K, Anderson B, Polonsky WH. Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire. Diabet Med 2003; 20: 69-72. (Pubitemid 36104203)
6. Sämann A, Mühlhauser I, Bender R, et al. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 2005; 48: 1965-70.
7. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin- dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
8. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271-286.
9. Egger M, Davey Smith G, Stettler C, Diem P. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997; 14: 919-928. (Pubitemid 27492182)
10. Davis RE, Morrissey M, Peters JR, et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin 2005; 21: 1477-1483. (Pubitemid 41368581)
11. National Association of Diabetes Centres. ANDIAB 2006 - Australian national diabetes information audit and benchmarking. Final report. Canberra: Australian Government Department of Health and Ageing, 2007.
12. National Institute for Clinical Excellence. Guidance on the use of patient-education models for diabetes. (Technology appraisal guidance 60.) London: NICE, 2003.
13. Shearer A, Bagust A, Sanderson D, et al. Cost-effectiveness of flexible intensive insulin management to enable dietary freedom in people with Type 1 diabetes in the UK. Diabet Med 2004; 21: 460-467. (Pubitemid 38608534)
14. Lowe J, Linjawi S, Mensch M, et al. Flexible eating and flexible insulin dosing in patients with diabetes: results of an intensive self-management course. Diabetes Res Clin Pract 2008; 80: 439-443.
15. Bendik CF, Keller U, Moriconi N, et al. Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes. Diabetes Res Clin Pract 2009; 83: 327-333.
16. Australian Government Department of Health and Ageing. Medicare Benefits Schedule. Allied Health Services. 1 May 2010. Part 4. Allied health group services for patients with type 2 diabetes. http://www.health.gov.au/internet/ mbsonline/publishing.nsf/Content/FD65645DA9682F63CA2576F60002194F/$File/ 201005-Allied.pdf (accessed 20 Apr 2010).